66th ASH Annual Meeting and Exposition - December 7-10, 2024
Venue: San Diego Convention Center 111 W Harbor Drive San Diego, CA 92101
Oncoletter übersetzt für Sie in Kooperation mit INFO@ONCO-SUISSE die Abstracts aus den klinisch orientierten Oral Sessions und fasst sie leicht lesbar zusammen. Damit bieten die Texte einen schnellen Überblick zu den wichtigsten Studien, die am ASH mündlich vorgestellt werden. Mittels eines Links kann jede Studie im Originalabstract nachgelesen werden.
Die Zusammenfassungen der Abstracts sowie Zeit und Ort der jeweiligen Präsentation werden ab dem 6. November schrittweise auf der Webseite aufgeschaltet.
Alle Zusammenfassungen der Late-Breaking Abstracts unterliegen einem Embargo und dürfen erst zum Zeitpunkt der Präsentation aufgeschaltet werden.
- ASH 24 Press Briefings on Late Breaking and other important Abstracts
- ASH 2024 Late-Breaking Abstracts Session
- ASH 2024 Plenary Scientific Session
-
Acute Lymphoblastic Leukemias
- ALL: Clinical and Epidemiological studies
-
ALL: Therapies, Excluding Allogeneic Transplantation:
- Risk Stratification and CAR-T Therapies: Monday, December 9, 2024: 4:30 PM-6:00 PM Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
- Treatment of BCR:ABL+ and T Cell Diseases: Monday, December 9, 2024: 2:45 PM-4:15 PM Marriott Grand Ballroom 2-4 (Marriott Marquis San Diego Marina)
- Clinical Trials in Pediatric and Young Adult Patients: Saturday, December 7, 2024: 4:00 PM-5:30 PM Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
-
Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis
- Genomic Determinants of Outcomes In ALL: Saturday, December 7, 2024: 4:00 PM-5:30 PM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
- Understanding and Exploiting Molecular Therapeutic Targets in ALL: Sunday, December 8, 2024: 4:30 PM-6:00 PM Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
- ALL Links to Poster Sessions
-
Acute Myeloid Leukemias
-
AML: Clinical and Epidemiological studies
- Treatments and Outcomes in AML in Specific Age Groups, and in Blastic Plasmacytoid Dendritic Cell Neoplasms: Saturday, December 7, 2024: 4:00 PM-5:30 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Frailty, Age, and Care Provisions-Impact on AML Outcomes: Sunday, December 8, 2024: 9:30 AM-11:00 AM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
- Genetic Markers and Outcomes in AML: Monday, December 9, 2024: 2:45 PM-4:15 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- AML: Investigational Drug and Cellular Therapies
-
AML: Commercially Available Therapies:
- Impact of Molecularly-Targeted Agents in AML: Saturday, December 7, 2024: 2:00 PM-3:30 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- How Do We Start? Upfront Regimens with Commercially Available Therapies: Saturday, December 7, 2024: 9:30 AM-11:00 AM Hall B (San Diego Convention Center)
- Optimizing Regimens in Children/Young Adults and Around the World: Monday, December 9, 2024: 4:30 PM-6:00 PM Grand Hall B (Manchester Grand Hyatt San Diego)
-
AML: Biomarkers and Molecular Markers in Diagnosis and Prognosis:
- Multi-omic Applications for Disease Evolution and Response to Therapy: Saturday, December 7, 2024: 9:30 AM-11:00 AM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Functional Genomics in Prognosis and Novel Therapies: Saturday, December 7, 2024: 4:00 PM-5:30 PM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
- Deciphering the Mechanisms Underlying Prognosis: Sunday, December 8, 2024: 4:30 PM-6:00 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Refining Diagnostic Risk Assessment: Monday, December 9, 2024: 2:45 PM-4:15 PM Grand Hall B (Manchester Grand Hyatt San Diego)
- AML: Disease Burden and Minimal Residual Disease in Prognosis and Treatment
- AML Links to Poster Sessions
-
AML: Clinical and Epidemiological studies
- Chronic Myeloid Leukemia
-
Myeloproliferative Syndromes and Chronic Myeloid Leukemia
-
Myeloproliferative Syndromes and Chronic Myeloid Leukemia
- MPS: Basic and Translational: Stem Cell Biology in Myeloproliferative Syndromes: Monday, December 9, 2024: 10:30 AM-12:00 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- MPS: Basic and Translational: New Insights into The Biology of Myeloproliferative Syndromes: Monday, December 9, 2024: 2:45 PM-4:15 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
-
MPS: Clinical and Epidemiological
- MPS: Risk Stratification and Therapeutic Implications: Saturday, December 7, 2024: 2:00 PM-3:30 PM Ballroom 20AB (San Diego Convention Center)
- MPS: Advancing Treatment Paradigms in Myeloproliferative Neoplasms and Mastocytosis: Sunday, December 8, 2024: 4:30 PM-6:00 PM Grand Hall D (Manchester Grand Hyatt San Diego)
- MPS: JAK Inhibitors in MPDs, Novel Insights and Next-Gen Agents: Sunday, December 8, 2024: 9:30 AM-11:00 AM Grand Hall C (Manchester Grand Hyatt San Diego)
- MPS: Advancing MPN Care: Innovative Therapies and Clinical Breakthroughs in Myelofibrosis: Monday, December 9, 2024: 4:30 PM-6:00 PM Harbor Ballroom DEFG (Manchester Grand Hyatt San Diego)
- Myeloproliferative Syndromes: Links to Poster Sessions
-
Myeloproliferative Syndromes and Chronic Myeloid Leukemia
-
Lymphomas
-
Lymphomas: Translational
- Molecular and genetic: Molecular Profiling and Targets in Aggressive Lymphomas: Saturday, December 7, 2024: 2:00 PM-3:30 PM Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
- Molecular and Genetic: Single-cell and Spatial Analyses in Aggressive and T Cell Lymphomas: Sunday, December 8, 2024: 9:30 AM-11:00 AM Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
- Molecular and Genetic: Single-cell and Spatial Analyses in Indolent Lymphomas: Monday, December 9, 2024: 10:30 AM-12:00 PM Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
- Molecular and Genetic: Molecular Profiling and Prognostic Biomarkers in Hodgkin and Non-Hodgkin Lymphomas: Monday, December 9, 2024: 2:45 PM-4:15 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
- Non-Genetic: Novel Immune Evasion Strategies in B Cell Lymphomas: Saturday, December 7, 2024: 4:00 PM-5:30 PM Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
- Non-Genetic: New Approaches and Models for Improving Lymphoma Therapies: Monday, December 9, 2024: 4:30 PM-6:00 PM Marriott Grand Ballroom 11-13 (Marriott Marquis San Diego Marina)
- Non-Genetic: Demystifying the Complexity of the Lymphoma Tumor Microenvironment and Immune Responses: Sunday, December 8, 2024: 4:30 PM-6:00 PM Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
-
Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological:
- Therapies for Mantle Cell Lymphoma: Saturday, December 7, 2024: 2:00 PM-3:30 PM Marriott Grand Ballroom 11-13 (Marriott Marquis San Diego Marina)
- Novel Treatment Strategies and New Data on Old Standards for Follicular Lymphoma: Saturday, December 7, 2024: 4:00 PM-5:30 PM Marriott Grand Ballroom 11-13 (Marriott Marquis San Diego Marina)
- Updates on Drug Treatments for Mantle Cell Lymphoma, and CAR-T and Transplants for Indolent Lymphomas: Monday, December 9, 2024: 10:30 AM-12:00 PM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
- Clinical and Epidemiological: Clinical Trials for Marginal Zone Lymphoma, Waldenstrom's Macroglobulinemia and Hairy Cell Leukemia: Monday, December 9, 2024: 2:45 PM-4:15 PM Marriott Grand Ballroom 11-13 (Marriott Marquis San Diego Marina)
- ASH Update Results Zanubrutinib & Video Statement
-
Hodgkin Lymphomas and T Cell, NK Cell, or NK/T Lymphomas
- Clinical and Epidemiological: Potentially Practice-Changing Trials in Hodgkin Lymphoma: Sunday, December 8, 2024: 9:30 AM-11:00 AM Ballroom 20AB (San Diego Convention Center)
- Clinical and Epidemiological: Optimization of Therapy: Sunday, December 8, 2024: 12:00 PM-1:30 PM Ballroom 20CD (San Diego Convention Center)
- T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Are We Ready to Move the Needle in T Cell Lymphomas? Monday, December 9, 2024: 4:30 PM-6:00 PM Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
- T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: When Old Meets New in T Cell Lymphomas: Sunday, December 8, 2024: 9:30 AM-11:00 AM Ballroom 20CD (San Diego Convention Center)
-
Aggressive Lymphomas
- Clinical and Epidemiological: CARs, Bispecifics, and ADCs: Progress and Challenges in Aggressive B Cell Lymphoma: Sunday, December 8, 2024: 9:30 AM-11:00 AM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
- Clinical and Epidemiological: Challenging Subtypes of Aggressive Lymphomas: Sunday, December 8, 2024: 12:00 PM-1:30 PM Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
- Clinical and Epidemiological: New Prognostic Tools and Treatment Outcomes in Diffuse Large B Cell Lymphoma: Sunday, December 8, 2024: 4:30 PM-6:00 PM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
- Pharmacologic Therapies: Novel Monotherapies or Novel Disease Indications: Monday, December 9, 2024: 2:45 PM-4:15 PM Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
- Pharmacologic Therapies: New R-CHOP Combinations for Treatment Naïve DLBCL: Sunday, December 8, 2024: 12:00 PM-1:30 PM Ballroom 20AB (San Diego Convention Center)
- Pharmacologic Therapies: Chemotherapy-free Combinations for Relapsed Aggressive Lymphomas: Monday, December 9, 2024: 4:30 PM-6:00 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
- Cellular Therapies: Novel Strategies for Cell Therapies in Aggressive Lymphomas: Saturday, December 7, 2024: 9:30 AM-11:00 AM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
- Lymphomas: Links to Poster Sessions
-
Lymphomas: Translational
-
Chronic Lymphocytic Leukemias
-
CLL - Clinical and Epidemiological:
- Frontline Targeted Therapy Combinations: Monday, December 9, 2024: 4:30 PM-6:00 PM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
- Mutations, Prognosis and MRD in CLL: Sunday, December 8, 2024: 12:00 PM-1:30 PM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
- Treating Refractory Disease-Novel Agents and Quality-of-Life: Monday, December 9, 2024: 2:45 PM-4:15 PM Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
- ASH Update Results Zanubrutinib & Video Statement
- Chronic Lymphocytic Leukemia: Link to Posters
-
CLL - Clinical and Epidemiological:
-
Myelodysplastic Syndromes
-
MDS
- Basic and Translational: Disease Mechanisms and Therapeutic Vulnerabilities in Molecular Genetic Subtypes of MDS: Saturday, December 7, 2024: 4:00 PM-5:30 PM Ballroom 20CD (San Diego Convention Center)
- Basic and Translational: Novel Mechanisms of Aberrant Hematopoiesis and Immune Evasion in MDS: Monday, December 9, 2024: 2:45 PM-4:15 PM Grand Hall D (Manchester Grand Hyatt San Diego)
- Clinical and Epidemiological: Defining and Treating Low Risk MDS: Saturday, December 7, 2024: 4:00 PM-5:30 PM Ballroom 20AB (San Diego Convention Center)
- Clinical and Epidemiological: Treatment and Prognostication of MDS: Sunday, December 8, 2024: 4:30 PM-6:00 PM Harbor Ballroom DEFG (Manchester Grand Hyatt San Diego)
- Clinical and Epidemiological: Defining and Treating Chronic Myelomonocytic Leukemia: Monday, December 9, 2024: 4:30 PM-6:00 PM Grand Hall D (Manchester Grand Hyatt San Diego)
- MDS: Link to Posters
-
MDS
-
Multiple Myeloma and Plasma Cell Dyscrasias
-
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational
- Genomic and Epigenomic Insights into Myeloma Outcomes: Saturday, December 7, 2024: 2:00 PM-3:30 PM San Diego Ballroom AB (Marriott Marquis San Diego Marina)
- Understanding and Improving TCE and CAR-T Cell Therapies for Plasma Cell Disorders: Saturday, December 7, 2024: 4:00 PM-5:30 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
- Resistance and Response to Anti-Myeloma Therapies: Sunday, December 8, 2024: 12:00 PM-1:30 PM San Diego Ballroom AB (Marriott Marquis San Diego Marina)
- Microenvironment and Immunity in Myeloma: Sunday, December 8, 2024: 4:30 PM-6:00 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
- Uncovering New Targets and Disease Mechanisms in Myeloma: Monday, December 9, 2024: 10:30 AM-12:00 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
-
Multiple Myeloma: Clinical and Epidemiological
- Advancing Minimal Residual Disease (MRD): Detection, Impact on Prognosis and Treatment Decisions: Saturday, December 7, 2024: 4:00 PM-5:30 PM San Diego Ballroom AB (Marriott Marquis San Diego Marina)
- Addressing Hematologic and Immune Toxicities and the Status of Quad Therapies: Saturday, December 7, 2024: 2:00 PM-3:30 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- Decluttering Responses and Dynamic Risk: How Can We Improve Prognostication in Multiple Myeloma? Saturday, December 7, 2024: 9:30 AM-11:00 AM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
- Cellular and Molecular Profiling of Multiple Myeloma: Implications for Clinical Practice: Sunday, December 8, 2024: 9:30 AM-11:00 AM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- Exploring T Cell Redirecting Therapies, Mutation Profiles and Early Relapse: Monday, December 9, 2024: 2:45 PM-4:15 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
-
Multiple Myeloma: Pharmacologic and Cellular Therapies
- Optimizing Therapy in Newly Diagnosed Myeloma and Beyond: Sunday, December 8, 2024: 4:30 PM-6:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- Refining the Evidence: Randomized Trials in Multiple Myeloma: Monday, December 9, 2024: 10:30 AM-12:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- Targeting BCMA: Sunday, December 8, 2024: 9:30 AM-11:00 AM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
- Into the Future: New Drugs and Combinations in Multiple Myeloma: Monday, December 9, 2024: 4:30 PM-6:00 PM Hall B (San Diego Convention Center)
- Cellular Therapies: Unleashing Cell Therapies Against Myeloma: Monday, December 9, 2024: 4:30 PM-6:00 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
-
MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias
- Clinical and Epidemiological: Ignored no Longer-Progress in AL Amyloidosis: Monday, December 9, 2024: 2:45 PM-4:15 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- Clinical and Epidemiological: Genes, Cells and Algorithms: Novel Methods of Predicting Progression in MGUS and SMM: Monday, December 9, 2024: 4:30 PM-6:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- Multiple Myeloma and Plasma Dyscrasias: Link to Posters
-
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational
-
CAR-T Cell and Cellular Immunotherapies other than CAR-T Cells
-
CAR-T Cell and Cellular Immunotherapies other than CAR-T Cells
- CAR-T Cell Therapies: Basic and Translational: Myeloid Biology and CAR-T Cells: Saturday, December 7, 2024: 4:00 PM-5:30 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- CAR-T Cell Therapies: Basic and Translational: Enhancements in CAR-T Cell Signaling, Delivery & Manufacturing: Sunday, December 8, 2024: 9:30 AM-11:00 AM Room 6A (San Diego Convention Center)
- CAR-T Cell Therapies: Basic and Translational: Acute and Late Toxicities Following CAR-T Cell Therapy: Monday, December 9, 2024: 2:45 PM-4:15 PM Room 6CF (San Diego Convention Center)
- CAR-T Cell Therapies: Basic and Translational: Novel Targets and Therapeutic Approaches for CAR-T Cells: Monday, December 9, 2024: 4:30 PM-6:00 PM Room 6CF (San Diego Convention Center)
- Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Novel Cell Platforms and Delivery Strategies: Saturday, December 7, 2024: 9:30 AM-11:00 AM Ballroom 20AB (San Diego Convention Center)
- Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Enhancing NK Cell Therapeutics: Monday, December 9, 2024: 2:45 PM-4:15 PM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
- Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Emerging Targeting Approaches of Cell Therapies for Hematologic Malignancies: Monday, December 9, 2024: 2:45 PM-4:15 PM Hall B (San Diego Convention Center)
- Cellular Immunotherapies: Early Phase Clinical Trials & Toxicities: CAR-T Cell Therapies for Lymphomas & ALL: New Strategies & Toxicities: Saturday, December 7, 2024: 9:30-11:00 AM Marriott Grand Ballroom 11-13 (Marriott Marquis San Diego Marina)
- Cellular Immunotherapies: Early Phase Clinical Trials & Toxicities: B Cell-directed CAR T Cell Therapies for ALL & for Autoimmunity: Sunday, December 8, 2024: 4:30 PM-6:00 PM Marriott Grand Ballroom 2-4 (Marriott Marquis San Diego Marina)
- Cell Therapies
-
CAR-T Cell and Cellular Immunotherapies other than CAR-T Cells